User login
If you haven’t started reporting quality data for the Merit-Based Incentive Payment System (MIPS), there’s still time to avoid a 4% cut to your Medicare payments.
Under the Pick Your Pace approach being offered this year, the Centers for Medicare & Medicaid Services allows clinicians to test the system by reporting on one quality measure for one patient through paper-based claims. Be sure to append a Quality Data Code (QDC) to the claim form for care provided up to Dec. 31, 2017, in order to avoid a penalty in payment year 2019.
Consider this measure:
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Measure #113: Colorectal Cancer Screening
This measure is aimed at capturing the percentage of patients aged 50-75 years who were screened for colorectal cancer.
What you need to do: The patient should be screened for colorectal cancer during calendar 2017 (or specified alternative time frame) using an appropriate test. Document the screening and results in the medical record.
Appropriate tests include:
- Fecal occult blood test (FOBT) during the performance period (calendar 2017).
- Flexible sigmoidoscopy during the performance period or the 4 years prior.
- Colonoscopy during the performance period or the 9 years prior.
- Computed tomography (CT) colonography during the performance period or the 4 years prior.
- Fecal immunochemical DNA test (FIT-DNA) during the measurement period or the 2 years prior.
Eligible cases include patients aged 50-75 years of age on the date of the encounter and a patient encounter during the performance period. Applicable codes include (CPT or HCPCS): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, G0402, G0438, G0439.
To get credit under MIPS, be sure to include a QDC that shows that you successfully performed the measure or had a good reason for not doing so. For instance, CPT II 3017F indicates that colorectal cancer screening results were documented and reviewed. The exclusion code G9711 should be used for patients with a diagnosis or past history of total colectomy or colorectal cancer.
CMS has a full list measures available for claims-based reporting at qpp.cms.gov. The American Medical Association has also created a step-by-step guide for reporting on one quality measure.
Certain clinicians are exempt from reporting and do not face a penalty under MIPS:
- Those who enrolled in Medicare for the first time during a performance period.
- Those who have Medicare Part B allowed charges of $30,000 or less.
- Those who have 100 or fewer Medicare Part B patients.
- Those who are significantly participating in an Advanced Alternative Payment Model (APM).
If you haven’t started reporting quality data for the Merit-Based Incentive Payment System (MIPS), there’s still time to avoid a 4% cut to your Medicare payments.
Under the Pick Your Pace approach being offered this year, the Centers for Medicare & Medicaid Services allows clinicians to test the system by reporting on one quality measure for one patient through paper-based claims. Be sure to append a Quality Data Code (QDC) to the claim form for care provided up to Dec. 31, 2017, in order to avoid a penalty in payment year 2019.
Consider this measure:
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Measure #113: Colorectal Cancer Screening
This measure is aimed at capturing the percentage of patients aged 50-75 years who were screened for colorectal cancer.
What you need to do: The patient should be screened for colorectal cancer during calendar 2017 (or specified alternative time frame) using an appropriate test. Document the screening and results in the medical record.
Appropriate tests include:
- Fecal occult blood test (FOBT) during the performance period (calendar 2017).
- Flexible sigmoidoscopy during the performance period or the 4 years prior.
- Colonoscopy during the performance period or the 9 years prior.
- Computed tomography (CT) colonography during the performance period or the 4 years prior.
- Fecal immunochemical DNA test (FIT-DNA) during the measurement period or the 2 years prior.
Eligible cases include patients aged 50-75 years of age on the date of the encounter and a patient encounter during the performance period. Applicable codes include (CPT or HCPCS): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, G0402, G0438, G0439.
To get credit under MIPS, be sure to include a QDC that shows that you successfully performed the measure or had a good reason for not doing so. For instance, CPT II 3017F indicates that colorectal cancer screening results were documented and reviewed. The exclusion code G9711 should be used for patients with a diagnosis or past history of total colectomy or colorectal cancer.
CMS has a full list measures available for claims-based reporting at qpp.cms.gov. The American Medical Association has also created a step-by-step guide for reporting on one quality measure.
Certain clinicians are exempt from reporting and do not face a penalty under MIPS:
- Those who enrolled in Medicare for the first time during a performance period.
- Those who have Medicare Part B allowed charges of $30,000 or less.
- Those who have 100 or fewer Medicare Part B patients.
- Those who are significantly participating in an Advanced Alternative Payment Model (APM).
If you haven’t started reporting quality data for the Merit-Based Incentive Payment System (MIPS), there’s still time to avoid a 4% cut to your Medicare payments.
Under the Pick Your Pace approach being offered this year, the Centers for Medicare & Medicaid Services allows clinicians to test the system by reporting on one quality measure for one patient through paper-based claims. Be sure to append a Quality Data Code (QDC) to the claim form for care provided up to Dec. 31, 2017, in order to avoid a penalty in payment year 2019.
Consider this measure:
The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
Measure #113: Colorectal Cancer Screening
This measure is aimed at capturing the percentage of patients aged 50-75 years who were screened for colorectal cancer.
What you need to do: The patient should be screened for colorectal cancer during calendar 2017 (or specified alternative time frame) using an appropriate test. Document the screening and results in the medical record.
Appropriate tests include:
- Fecal occult blood test (FOBT) during the performance period (calendar 2017).
- Flexible sigmoidoscopy during the performance period or the 4 years prior.
- Colonoscopy during the performance period or the 9 years prior.
- Computed tomography (CT) colonography during the performance period or the 4 years prior.
- Fecal immunochemical DNA test (FIT-DNA) during the measurement period or the 2 years prior.
Eligible cases include patients aged 50-75 years of age on the date of the encounter and a patient encounter during the performance period. Applicable codes include (CPT or HCPCS): 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, 99350, G0402, G0438, G0439.
To get credit under MIPS, be sure to include a QDC that shows that you successfully performed the measure or had a good reason for not doing so. For instance, CPT II 3017F indicates that colorectal cancer screening results were documented and reviewed. The exclusion code G9711 should be used for patients with a diagnosis or past history of total colectomy or colorectal cancer.
CMS has a full list measures available for claims-based reporting at qpp.cms.gov. The American Medical Association has also created a step-by-step guide for reporting on one quality measure.
Certain clinicians are exempt from reporting and do not face a penalty under MIPS:
- Those who enrolled in Medicare for the first time during a performance period.
- Those who have Medicare Part B allowed charges of $30,000 or less.
- Those who have 100 or fewer Medicare Part B patients.
- Those who are significantly participating in an Advanced Alternative Payment Model (APM).